RAAB G KIRK 4
4 · Transcept Pharmaceuticals Inc · Filed Feb 3, 2011
Insider Transaction Report
Form 4
RAAB G KIRK
Director
Transactions
- Award
Stock Option (right to buy)
2011-02-02+38,000→ 38,000 totalExercise: $8.20Exp: 2021-02-02→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]The option vests in forty-eight equal monthly installments beginning February 27, 2011.